Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited)

v3.19.2
Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Beginning Balance at Dec. 31, 2018 $ 33,661 $ 3,566,339 $ (9,296,408) $ (370,132) $ (6,066,540)
Beginning Balance, Shares at Dec. 31, 2018 33,661,388        
Purchase Accounting entries due to the purchase transaction (note 3) $ 9 $ 24,717 12,657,182 12,681,908
Purchase Accounting entries due to the purchase transaction, shares 9,250 24,717,217        
Adjustment for assets and liabilities not included in purchase transaction 5,244,780 5,244,780
Issuance of common stock in connection with private placement offering from January 8, 2019 through June 30, 2019 $ 17,500 4,324,923 4,342,423
Issuance of common stock in connection with private placement offering from January 8, 2019 through June 30, 2019, shares 17,500,000        
Issuance of warrants in connection with private placement offering from January 8, 2019 through June 30, 2019 2,641,161 2,641,161
Issuance of common stock pursuant to conversion of short-term debt in January 2019 $ 500 125,437 125,937
Issuance of common stock pursuant to conversion of short-term debt in January 2019, shares 500,000        
Issuance of warrants pursuant to conversion of short-term debt in January 2019 74,063 74,063
Issuance of additional exchange shares - Note 3 $ 17,264 (17,264)
Issuance of additional exchange shares - Note 3, shares 17,263,889        
Issuance of common stock pursuant to conversion of short-term debt in February 2019 $ 250 99,750 100,000
Issuance of common stock pursuant to conversion of short-term debt in February 2019, shares 250,000        
Issuance of common stock pursuant to conversion of convertible Preferred Series B Stock conversions $ (2) $ 513 (511)
Issuance of common stock pursuant to conversion of convertible Preferred Series B Stock conversions, shares (2,050) 512,500        
Issuance of common stock pursuant to conversion of short-term debt accrued interest $ 2 665 667
Issuance of common stock pursuant to conversion of short-term debt accrued interest, shares 1,667        
Issuance of common stock pursuant to conversion of convertible Preferred Series B Stock accrued interest $ 32 12,894 12,926
Issuance of common stock pursuant to conversion of convertible Preferred Series B Stock accrued interest, shares 32,313        
Issuance of common stock in March 2019 in exchange for consulting fees incurred in Q1 2019 $ 130 51,904 52,034
Issuance of common stock in March 2019 in exchange for consulting fees incurred in Q1 2019, shares 130,085        
Issuance of common stock in private placement, completed in April 2019 at $0.40 pursuant to security purchase agreement dated March 31, 2019
Issuance of warrants in private placement, completed in April 2019 at $0.40 pursuant to security purchase agreement dated March 31, 2019
Adjustment of exercise price of certain warrants 404,384 (404,384)
Beneficial conversion of preferred series B stock 32,592 (32,592)
Issuance of common stock pursuant to conversion of Preferred Series B Stock conversions $ 50 (50)
Issuance of common stock pursuant to conversion of Preferred Series B Stock conversions, shares (200) 50,000        
Issuance of common stock pursuant to conversion of Preferred Series B Stock accrued dividends $ 42 (42)
Issuance of common stock pursuant to conversion of Preferred Series B Stock accrued dividends, shares 41,667        
Issuance of common stock per restricted stock award to executive (Note 9) $ 4,226 1,686,028 1,690,254
Issuance of common stock per restricted stock award to executive (Note 9), shares 4,225,634        
Stock based compensation 92,159 92,159
Dividend payable (45,639) (45,639)
Net loss (8,992,087) (8,992,087)
Ending Balance at Jun. 30, 2019 $ 7 $ 98,887 25,705,975 (13,480,691) (370,132) 11,954,046
Ending Balance, shares at Jun. 30, 2019 7,000 98,886,360        
Beginning Balance at Mar. 31, 2019 $ 7 $ 94,037 17,610,529 (8,183,420) (370,132) 9,151,021
Beginning Balance, Shares at Mar. 31, 2019 7,200 94,036,746        
Purchase Accounting entries due to the purchase transaction (note 3) 6,215,000 6,215,000
Purchase Accounting entries due to the purchase transaction, shares        
Issuance of common stock in connection with private placement offering from January 8, 2019 through June 30, 2019 $ 500 123,977   124,477
Issuance of common stock in connection with private placement offering from January 8, 2019 through June 30, 2019, shares 500,000        
Issuance of warrants in connection with private placement offering from January 8, 2019 through June 30, 2019 75,523 75,523
Issuance of common stock pursuant to conversion of convertible Preferred Series B Stock accrued interest 32 12,893 12,926
Issuance of common stock pursuant to conversion of convertible Preferred Series B Stock accrued interest, shares 32,313        
Issuance of common stock pursuant to conversion of Preferred Series B Stock conversions $ 50 (50)
Issuance of common stock pursuant to conversion of Preferred Series B Stock conversions, shares (200) 50,000        
Series B Stock accrued dividends $ 42 (42)
Series B Stock accrued dividends, shares 41,667        
Issuance of restricted common stock pursuant to executive employment agreement $ 4,226 1,686,028 1,690,254
Issuance of restricted common stock pursuant to executive employment agreement, shares 4,225,634        
Stock based compensation 3,116 3,116
Dividend payable (21,000) (21,000)
Net loss (5,297,271) (5,297,271)
Ending Balance at Jun. 30, 2019 $ 7 $ 98,887 $ 25,705,975 $ (13,480,691) $ (370,132) $ 11,954,046
Ending Balance, shares at Jun. 30, 2019 7,000 98,886,360